Unbalanced Redox With Autophagy in Cardiovascular Disease

키워드

참고문헌 (169)

1. Khosravi M, "The effects of oxidative stress on the development of atherosclerosis", Biol Chem, 400, pp.711~732 (2019)
2. Hopkins BL, "Redoxins as gatekeepers of the transcriptional oxidative stress response", Redox Biol, 21, pp.101104~ (2019)
3. Seifried HE, "A review of the interaction among dietary antioxidants and reactive oxygen species", J Nutr Biochem, 18, pp.567~579 (2007)
4. Sies H, "Reactive oxygen species(ROS)as pleiotropic physiological signalling agents", Nat Rev Mol Cell Biol, 21, pp.363~383 (2020)
5. Kamata H, "Redox regulation of cellular signalling", Cell Signal, 11, pp.1~14 (1999)
6. Yang S, "ROS and diseases : role in metabolism and energy supply", Mol Cell Biochem, 467, pp.1~12 (2020)
7. Birben E, "Oxidative stress and antioxidant defense", World Allergy Organ J, 5, pp.9~19 (2012)
8. Rhee SG, "Hydrogen peroxide : a key messenger that modulates protein phosphorylation through cysteine oxidation", Sci STKE, 2000, pp.pe1~ (2000)
9. Arthur JR, "The glutathione peroxidases", Cell Mol Life Sci, 57, pp.1825~1835 (2000)
10. Biaglow JE, "The thioredoxin reductase", thioredoxin system : novel redox targets for cancer therapy, 2005, pp.4, 6~13
11. Valko M, "Free radicals and antioxidants in normal physiological functions and human disease", Int J Biochem Cell Biol, 39, pp.44~84 (2007)
12. Oguntibeju OO, "Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links", Int J Physiol Pathophysiol Pharmacol, 11, pp.45~63 (2019)[DOI]
13. Yazan Ranneh, "Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review", Applied Biological Chemistry, 60(3), pp.327~338 (2017), 한국응용생명화학회
14. Reuter S, "Oxidative stress, inflammation, and cancer : how are they linked?", Free Radic Biol Med, 49, pp.1603~1616 (2010)
15. Sikand G, "Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction", Am J Prev Cardiol, 4, pp.100106~ (2020)
16. He C, "Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis", Nature, 481, pp.511~515 (2012)
17. Ohsumi Y, "Historical landmarks of autophagy research", Cell Res, 24, pp.9~23 (2014)
18. Perrotta I, "Macrophage autophagy and oxidative stress : an ultrastructural and immunoelectron microscopical study", Oxid Med Cell Longev, 2011, pp.282739~ (2011)
19. Scherz-Shouval R, "Regulation of autophagy by ROS : physiology and pathology", Trends Biochem Sci, 36, pp.30~38 (2011)
20. Zhang Y, "Induction of autophagy is essential for monocyte-macrophage differentiation", Blood, 119, pp.2895~2905 (2012)
21. Moore KJ, "Macrophages in the pathogenesis of atherosclerosis", Cell, 145, pp.341~355 (2011)
22. Libby P, "Progress and challenges in translating the biology of atherosclerosis", Nature, 473, pp.317~325 (2011)
23. Andreou DE, "Atherosclerosis : an inflammatory disease", Pharmakeftiki, 22, pp.83~96 (2009)
24. Hansson GK, "The immune system in atherosclerosis", Nat Immunol, 12, pp.204~212 (2011)
25. Song P, "Global and regional prevalence, burden, and risk factors for carotid atherosclerosis : a systematic review, meta-analysis, and modelling study", Lancet Glob Health, 8, pp.e721~e729 (2020)
26. Milutinović A, "Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries : an updated review", Bosn J Basic Med Sci, 20, pp.21~30 (2020)
27. Rafieian-Kopaei M, "Atherosclerosis : process, indicators, risk factors and new hopes", Int J Prev Med, 5, pp.927~946 (2014)
28. Yang S, "Macrophage polarization in atherosclerosis", Clin Chim Acta, 501, pp.142~146 (2020)
29. Sorokin V, "Role of vascular smooth muscle cell plasticity and interactions in vessel wall inflammation", Front Immunol, 11, pp.599415~ (2020)
30. Doran AC, "Role of smooth muscle cells in the initiation and early progression of atherosclerosis", Arterioscler Thromb Vasc Biol, 28, pp.812~819 (2008)
31. Khatana C, "Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis", Oxid Med Cell Longev, 2020, pp.5245308~ (2020)
32. Su LJ, "Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis", Oxid Med Cell Longev, 2019, pp.5080843~ (2019)
33. Podrez EA, "Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species", J Clin Invest, 105, pp.1095~1108 (2000)
34. Kunjathoor VV, "Scavenger receptors class A-I", II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages, 2002, pp.277, 49982~49988
35. Febbraio M, "Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice", J Clin Invest, 105, pp.1049~1056 (2000)
36. Janabi M, "Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients", Arterioscler Thromb Vasc Biol, 20, pp.1953~1960 (2000)
37. Park YM, "CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima", J Clin Invest, 119, pp.136~145 (2009)
38. Moore KJ, "Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice", J Clin Invest, 115, pp.2192~2201 (2005)
39. Maxeiner H, "Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2", J Exp Med, 188, pp.2257~2265 (1998)
40. Allen RM, "LDL delivery of microbial small RNAs drives atherosclerosis through macrophage TLR8", Nat Cell Biol, 24, pp.1701~1713 (2022)
41. Cokic I, "Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium", Nat Commun, 13, pp.6394~ (2022)
42. Morris G, "Redox regulation of the immune response", Cell Mol Immunol, 19, pp.1079~1101 (2022)
43. Khan SY, "Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin", Sci Rep, 7, pp.39501~ (2017)
44. Ting KK, "The aging endothelium", Vasc Biol, 3, pp.R35~R47 (2021)
45. Lozhkin A, "NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis", J Mol Cell Cardiol, 102, pp.10~21 (2017)
46. Chahine MN, "Oxidized LDL enhances stretch-induced smooth muscle cell proliferation through alterations in nuclear protein import", Can J Physiol Pharmacol, 90, pp.1559~1568 (2012)
47. Peng W, "Mitochondrial dysfunction in atherosclerosis", DNA Cell Biol, 38, pp.597~606 (2019)
48. Liu CS, "Alteration of the copy number of mitochondrial DNA in leukocytes of patients with hyperlipidemia", Ann N Y Acad Sci, 1042, pp.70~75 (2005)
49. Esposito LA, "Mitochondrial disease in mouse results in increased oxidative stress", Proc Natl Acad Sci U S A, 96, pp.4820~4825 (1999)
50. Chan DC, "Mitochondrial dynamics and its involvement in disease", Annu Rev Pathol, 15, pp.235~259 (2020)
51. Madamanchi NR, "Mitochondrial dysfunction in atherosclerosis", Circ Res, 100, pp.460~473 (2007)
52. Kinscherf R, "Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL : its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits", FASEB J, 11, pp.1317~1328 (1997)
53. Nishikawa T, "Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage", Nature, 404, pp.787~790 (2000)
54. Wilson FH, "A cluster of metabolic defects caused by mutation in a mitochondrial tRNA", Science, 306, pp.1190~1194 (2004)
55. Quan Y, "Mitochondrial ROS-modulated mtDNA : a potential target for cardiac aging", Oxid Med Cell Longev, 2020, pp.9423593~ (2020)
56. Ballinger SW, "Mitochondrial integrity and function in atherogenesis", Circulation, 106, pp.544~549 (2002)
57. Harrison CM, "Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production", Environ Health Perspect, 119, pp.676~681 (2011)
58. Ballinger SW, "Hydrogen peroxide-and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells", Circ Res, 86, pp.960~966 (2000)
59. Piantadosi CA, "Mitochondrial DNA, oxidants, and innate immunity", Free Radic Biol Med, 152, pp.455~461 (2020)
60. Cannizzo B, "Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression", Free Radic Res, 48, pp.526~533 (2014)
61. Libby P, "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2002)
62. Hansson GK, "The immune response in atherosclerosis : a double-edged sword", Nat Rev Immunol, 6, pp.508~519 (2006)
63. Lu N, "NLRP3-mediated inflammation in atherosclerosis and associated therapeutics", Front Cell Dev Biol, 10, pp.823387~ (2022)
64. Kim YW, "Inflammation and oxidative stress in angiogenesis and vascular disease", J Mol Med(Berl), 91, pp.323~328 (2013)
65. Kong P, "Inflammation and atherosclerosis : signaling pathways and therapeutic intervention", Signal Transduct Target Ther, 7, pp.131~ (2022)
66. Hopps E, "A novel component of the metabolic syndrome : the oxidative stress", Nutr Metab Cardiovasc Dis, 20, pp.72~77 (2010)
67. Iyer A, "Inflammatory lipid mediators in adipocyte function and obesity", Nat Rev Endocrinol, 6, pp.71~82 (2010)
68. Leopold JA, "Oxidative risk for atherothrombotic cardiovascular disease", Free Radic Biol Med, 47, pp.1673~1706 (2009)
69. Hussain T, "Oxidative stress and inflammation : what polyphenols can do for us?", Oxid Med Cell Longev, 2016, pp.7432797~ (2016)
70. Sharma A, "Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications : therapeutic implications", Front Physiol, 9, pp.114~ (2018)
71. Duewell P, "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals", Nature, 464, pp.1357~1361 (2010)
72. Zheng D, "Inflammasome activation and regulation : toward a better understanding of complex mechanisms", Cell Discov, 6, pp.36~ (2020)
73. Wang Z, "NLRP3 inflammasome and inflammatory diseases", Oxid Med Cell Longev, 2020, pp.4063562~ (2020)
74. Heid ME, "Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation", J Immunol, 191, pp.5230~5238 (2013)
75. Zhang H, "Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes", macrophages, 2016, pp.14, 156~
76. Yang Y, "Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors", Cell Death Dis, 10, pp.128~ (2019)
77. Wang R, "Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in ApoE-deficient mice", Lab Invest, 97, pp.922~934 (2017)
78. Zhang X, "Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis", Autophagy, 19, pp.886~903 (2023)
79. Liu S, "HHcy induces pyroptosis and atherosclerosis via the lipid raft-mediated NOX-ROS-NLRP3 inflammasome pathway in ApoE-", -mice, 2022, pp.11, 2438~
80. Bullón P, "Could NLRP3-inflammasome be a cardiovascular risk biomarker in acute myocardial infarction patients?", Antioxid Redox Signal, 27, pp.269~275 (2017)
81. Sokolova M, "NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction", Am J Physiol Endocrinol Metab, 315, pp.E912~E923 (2018)
82. Je-Wook Yu, "Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance", Archives of Pharmacal Research, 39(11), pp.1503~1518 (2016), 대한약학회
83. Brandes RP, "Vascular NADPH oxidases : molecular mechanisms of activation", Cardiovasc Res, 65, pp.16~27 (2005)
84. Förstermann U, "Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis", Circ Res, 120, pp.713~735 (2017)
85. Li H, "Vascular oxidative stress, nitric oxide and atherosclerosis", Atherosclerosis, 237, pp.208~219 (2014)
86. Patterson C, "Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox)may participate in forming this oxidase in vitro and in vivo", J Biol Chem, 274, pp.19814~19822 (1999)
87. Ushio-Fukai M, "p22phox is a critical component of the superoxide-generating NADH", NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells, 1996, pp.271, 23317~23321
88. Hilenski LL, "Vascular medicine: a companion to Braunwald’s heart disease", pp.25~42 (2013), Saunders
89. Park JM, "NADPH oxidase 1 mediates acute blood pressure response to angiotensin II by contributing to calcium influx in vascular smooth muscle cells", Arterioscler Thromb Vasc Biol, 42, pp.e117~ (2022)
90. Judkins CP, "Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-", -mice, 2010, pp.298, H24~H32
91. Azumi H, "Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris : important role of NAD(P)H oxidase", Arterioscler Thromb Vasc Biol, 22, pp.1838~1844 (2002)
92. Kalinina N, "Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions", Arterioscler Thromb Vasc Biol, 22, pp.2037~2043 (2002)
93. Pandey AK, "Expression of CD70 modulates nitric oxide and redox status in endothelial cells", Arterioscler Thromb Vasc Biol, 42, pp.1169~1185 (2022)
94. Sobenin IA, "Association of mitochondrial genetic variation with carotid atherosclerosis", PLoS One, 8, pp.e68070~ (2013)
95. Li X, "Mitochondrial reactive oxygen species mediate lysophosphatidylcholine-induced endothelial cell activation", Arterioscler Thromb Vasc Biol, 36, pp.1090~1100 (2016)
96. Song M, "Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy", Circ Res, 115, pp.348~353 (2014)
97. Ming XF, "Arginase II promotes macrophage inflammatory responses through mitochondrial reactive oxygen species, contributing to insulin resistance and atherogenesis", J Am Heart Assoc, 1, pp.e000992~ (2012)
98. Wang Y, "Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages", Circ Res, 114, pp.421~433 (2014)
99. Li J, "Electronic cigarettes induce mitochondrial DNA damage and trigger TLR9(Toll-like receptor 9)-mediated atherosclerosis", Arterioscler Thromb Vasc Biol, 41, pp.839~853 (2021)
100. Hou Y, "CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys", Cell Death Dis, 12, pp.523~ (2021)
101. Chen ML, "Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway", J Am Heart Assoc, 6, pp.e006347~ (2017)
102. Usui F, "Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm", Arterioscler Thromb Vasc Biol, 35, pp.127~136 (2015)
103. Nakahira K, "Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome", Nat Immunol, 12, pp.222~230 (2011)
104. Nakashima Y, "Attenuating effect of Chlorella extract on NLRP3 inflammasome activation by mitochondrial reactive oxygen species", Front Nutr, 8, pp.763492~ (2021)
105. Taniyama Y, "Reactive oxygen species in the vasculature : molecular and cellular mechanisms", Hypertension, 42, pp.1075~1081 (2003)
106. Cervantes Gracia K, "CVD and oxidative stress", J Clin Med, 6, pp.22~ (2017)
107. Choi MH, "Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II", Nature, 435, pp.347~353 (2005)
108. Ouimet M, "Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase", Cell Metab, 13, pp.655~667 (2011)
109. Liao X, "Macrophage autophagy plays a protective role in advanced atherosclerosis", Cell Metab, 15, pp.545~553 (2012)
110. 정세진, "The Role of Macrophage Lipophagy in Reverse Cholesterol Transport", Endocrinology and Metabolism, 32(1), pp.41~46 (2017), 대한내분비학회
111. Emanuel R, "Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae", Arterioscler Thromb Vasc Biol, 34, pp.1942~1952 (2014)
112. Le Guezennec X, "Wip1-dependent regulation of autophagy, obesity, and atherosclerosis", Cell Metab, 16, pp.68~80 (2012)
113. Shreeram S, "Wip1 phosphatase modulates ATM-dependent signaling pathways", Mol Cell, 23, pp.757~764 (2006)
114. Han XB, "Upconversion nanoparticle-mediated photodynamic therapy induces autophagy and cholesterol efflux of macrophage-derived foam cells via ROS generation", Cell Death Dis, 8, pp.e2864~ (2017)
115. Razani B, "Autophagy links inflammasomes to atherosclerotic progression", Cell Metab, 15, pp.534~544 (2012)
116. Magné J, "ATG16L1 expression in carotid atherosclerotic plaques is associated with plaque vulnerability", Arterioscler Thromb Vasc Biol, 35, pp.1226~1235 (2015)
117. Wang Y, "Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis", Biochim Biophys Acta Mol Cell Biol Lipids, 1863, pp.726~733 (2018)
118. Jeong SJ, "Prdx1(peroxiredoxin 1)deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux", Autophagy, 14, pp.120~133 (2018)
119. Shan R, "Apoptosis, autophagy and atherosclerosis : relationships and the role of Hsp27", Pharmacol Res, 166, pp.105169~ (2021)
120. Tabas I, "Macrophage death and defective inflammation resolution in atherosclerosis", Nat Rev Immunol, 10, pp.36~46 (2010)
121. Park JG, "Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice", Circ Res, 109, pp.739~749 (2011)
122. Shen W, "Oxidative stress mediates chemerin-induced autophagy in endothelial cells", Free Radic Biol Med, 55, pp.73~82 (2013)
123. Liu W, "Low shear stress inhibits endothelial mitophagy via caveolin-1", miR-7-5p, Atherosclerosis, pp.2022, 356[DOI]
124. Bharath LP, "Impairment of autophagy in endothelial cells prevents shear-stress-induced increases in nitric oxide bioavailability", Can J Physiol Pharmacol, 92, pp.605~612 (2014)
125. Tahrir FG, "Mitochondrial quality control in cardiac cells : mechanisms and role in cardiac cell injury and disease", J Cell Physiol, 234, pp.8122~8133 (2019)
126. Wang Y, "MicroRNA-103 protects coronary artery endothelial cells against h2o2-induced oxidative stress via BNIP3-mediated end-stage autophagy and antipyroptosis pathways", Oxid Med Cell Longev, 2020, pp.8351342~ (2020)
127. Takagaki Y, "Endothelial autophagy deficiency induces IL6-dependent endothelial mesenchymal transition and organ fibrosis", Autophagy, 16, pp.1905~1914 (2020)
128. Hu M, "Substrate stiffness differentially impacts autophagy of endothelial cells and smooth muscle cells", Bioact Mater, 6, pp.1413~1422 (2020)
129. Zhao Q, "TRPM2 promotes autophagic degradation in vascular smooth muscle cells", Sci Rep, 10, pp.20719~ (2020)
130. Qiao L, "Deficient chaperone-mediated autophagy promotes inflammation and atherosclerosis", Circ Res, 129, pp.1141~1157 (2021)
131. Nahapetyan H, "Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids", Atherosclerosis, 252, pp.e200~ (2016)
132. Grootaert MO, "Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis", Autophagy, 11, pp.2014~2032 (2015)
133. Kigawa Y, "NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice", Arterioscler Thromb Vasc Biol, 34, pp.2413~2420 (2014)
134. Jeong Se-Jin, "Deficiency of peroxiredoxin 2 exacerbates angiotensin II-induced abdominal aortic aneurysm", Experimental and Molecular Medicine, 52, pp.1~15 (2020), 생화학분자생물학회[DOI]
135. Kubota Y, "Lipoprotein(a)and abdominal aortic aneurysm risk : the Atherosclerosis Risk in Communities study", Atherosclerosis, 268, pp.63~67 (2018)
136. Li R, "EZH2 inhibits autophagic cell death of aortic vascular smooth muscle cells to affect aortic dissection", Cell Death Dis, 9, pp.180~ (2018)
137. Osonoi Y, "Defective autophagy in vascular smooth muscle cells enhances cell death and atherosclerosis", Autophagy, 14, pp.1991~2006 (2018)
138. Guo J, "Metformin protects against abdominal aortic aneurysm by Atg7-induced autophagy", Adv Clin Exp Med, 31, pp.59~69 (2022)
139. Mochida A, "Defective autophagy in vascular smooth muscle cells enhances the healing of abdominal aortic aneurysm", Physiol Rep, 9, pp.e15000~ (2021)
140. Wang Y, "Dynamic autophagic activity affected the development of thoracic aortic dissection by regulating functional properties of smooth muscle cells", Biochem Biophys Res Commun, 479, pp.358~364 (2016)
141. Irace FG, "Role of oxidative stress and autophagy in thoracic aortic aneurysms", JACC Basic Transl Sci, 6, pp.719~730 (2021)
142. Virani SS, "Heart Disease and Stroke Statistics-2021 update : a report from the American Heart Association", Circulation, 143, pp.e254~e743 (2021)
143. Xie H, "Identification of featured metabolism-related genes in patients with acute myocardial infarction", Dis Markers, 2020, pp.8880004~ (2020)
144. Yan F, "Loss of Wip1 aggravates brain injury after ischaemia", reperfusion by overactivating microglia, 2021, pp.6, 344~351
145. Zuo W, "Mitochondria autophagy is induced after hypoxic", ischemic stress in a Drp1 dependent manner : the role of inhibition of Drp1 in ischemic brain damage, 2014, pp.86, 103~115
146. Huang J, "The role of mitochondrial quality control in cardiac ischemia", reperfusion injury, 2021, pp.2021, 5543452~
147. Kamada Y, "Tor-mediated induction of autophagy via an Apg1 protein kinase complex", J Cell Biol, 150, pp.1507~1513 (2000)
148. Matsui Y, "Distinct roles of autophagy in the heart during ischemia and reperfusion : roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy", Circ Res, 100, pp.914~922 (2007)
149. Pattison JS, "Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes", Circ Res, 109, pp.151~160 (2011)
150. Kaizuka T, "Atg13 is essential for autophagy and cardiac development in mice", Mol Cell Biol, 36, pp.585~595 (2015)
151. Salo PP, "Genetic variants on chromosome 1p13. 3 are associated with non-ST elevation myocardial infarction and the expression of DRAM2 in the Finnish population", PLoS One, 10, pp.e0140576~ (2015)
152. Song E, "Cardiac autophagy deficiency attenuates ANP production and disrupts myocardial-adipose cross talk, leading to increased fat accumulation and metabolic dysfunction", Diabetes, 70, pp.51~61 (2021)
153. Xiao C, "Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b", Circ Res, 123, pp.564~578 (2018)
154. Ma X, "Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia", reperfusion injury, 2012, pp.125, 3170~3181
155. Qian J, "Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia", reperfusion injury by suppressed autophagy and increased cell death, 2009, pp.105, 1223~1231
156. Chen W, "Hyperbaric oxygen protects against myocardial ischemia-reperfusion injury through inhibiting mitochondria dysfunction and autophagy", Mol Med Rep, 22, pp.4254~4264 (2020)
157. Wu D, "The role of autophagy in acute myocardial infarction", Front Pharmacol, 10, pp.551~ (2019)
158. Sciarretta S, "Trehalose-induced activation of autophagy improves cardiac remodeling after myocardial infarction", J Am Coll Cardiol, 71, pp.1999~2010 (2018)
159. Kanamori H, "The role of autophagy emerging in postinfarction cardiac remodelling", Cardiovasc Res, 91, pp.330~339 (2011)
160. Kanamori H, "Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion", Am J Physiol Heart Circ Physiol, 300, pp.H2261~H2271 (2011)
161. Maejima Y, "Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2", Nat Med, 19, pp.1478~1488 (2013)
162. Koch JC, "The role of autophagy in axonal degeneration of the optic nerve", Exp Eye Res, 144, pp.81~89 (2016)
163. Liton PB, "The autophagic lysosomal system in outflow pathway physiology and pathophysiology", Exp Eye Res, 144, pp.29~37 (2016)
164. Hyman DJ, "Characteristics of patients with uncontrolled hypertension in the United States", N Engl J Med, 345, pp.479~486 (2001)
165. NCD Risk Factor Collaboration(NCD-RisC), "Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants", Lancet, 398, pp.957~980 (2021)
166. Zhu H, "Cardiac autophagy is a maladaptive response to hemodynamic stress", J Clin Invest, 117, pp.1782~1793 (2007)
167. Nakai A, "The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress", Nat Med, 13, pp.619~624 (2007)
168. Chao YM, "Redox-sensitive endoplasmic reticulum stress and autophagy at rostral ventrolateral medulla contribute to hypertension in spontaneously hypertensive rats", Hypertension, 61, pp.1270~1280 (2013)
169. Kwon Y, "Effects of 3-methyladenine, an autophagy inhibitor, on the elevated blood pressure and arterial dysfunction of angiotensin II-induced hypertensive mice", Biomed Pharmacother, 154, pp.113588~ (2022)

관련 논문AI추천